Search Results

Displaying Results 1-1 of 1 "'AGTC'"

Feb 25, 2026, 09:00 ET Foundation Fighting Blindness to Host Free Webinar on Regenerative Medicine Advances for Retinal Diseases

a clinical development leader within the ophthalmology therapeutic area at BlueRock Therapeutics. Prior to joining BlueRock, Dr. Beasley worked at AGTC, advancing gene therapy assets for inherited retinal degenerations, including retinitis pigmentosa, X-linked retinoschisis, and achromatopsia. She also

More news about: Foundation Fighting Blindness


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.